LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 19.69 | 84.90 | 10 | 1239 | 0.0081 | -0.4248 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 19.69 | 84.90 | 1458 | 1239 | 1.1763 | 1.0858 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 19.69 | 84.90 | 1268 | 1239 | 1.0231 | 1.0118 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 19.69 | 84.90 | 1426 | 1239 | 1.1505 | 1.0738 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.40 | 84.90 | 21 | 1454 | 0.0144 | -0.2888 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.40 | 84.90 | 1584 | 1454 | 1.0889 | 1.0420 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.40 | 84.90 | 1329 | 1454 | 0.9136 | 0.9564 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.40 | 84.90 | 1534 | 1454 | 1.0545 | 1.0261 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.10 | 84.90 | 20 | 1616 | 0.0124 | -0.2883 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.10 | 84.90 | 1701 | 1616 | 1.0525 | 1.0242 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.10 | 84.90 | 1563 | 1616 | 0.9671 | 0.9843 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.10 | 84.90 | 1678 | 1616 | 1.0382 | 1.0177 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.81 | 84.90 | 29 | 1769 | 0.0164 | -0.2174 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.81 | 84.90 | 1836 | 1769 | 1.0376 | 1.0169 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.81 | 84.90 | 1713 | 1769 | 0.9681 | 0.9852 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.81 | 84.90 | 1806 | 1769 | 1.0206 | 1.0093 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 26.51 | 84.90 | 42 | 1923 | 0.0218 | -0.1447 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 26.51 | 84.90 | 1939 | 1923 | 1.0082 | 1.0036 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 26.51 | 84.90 | 1838 | 1923 | 0.9557 | 0.9800 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 26.51 | 84.90 | 1934 | 1923 | 1.0056 | 1.0025 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 28.21 | 84.90 | 43 | 2091 | 0.0206 | -0.1368 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 28.21 | 84.90 | 2100 | 2091 | 1.0041 | 1.0018 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 28.21 | 84.90 | 1931 | 2091 | 0.9233 | 0.9658 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 28.21 | 84.90 | 2023 | 2091 | 0.9672 | 0.9856 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.92 | 84.90 | 57 | 2237 | 0.0255 | -0.0809 | MN20160318_Q02 | F15 |